University Of Oxford To Study Nasal Administration Of COVID-19 Vaccine
The title of this post, is the same as that of this article on the University of Oxford web site.
These two introductory paragraphs outline the structure of the tests.
The Phase I trial, which will enrol 30 healthy volunteers aged 18–40, will investigate the level of immune system responses generated by the vaccine using this delivery technique, as well as monitoring safety and for any adverse reactions.
All of the volunteers will receive the same vaccine that is currently being delivered by intramuscular injection as part of the national roll out of the ChAdOx1 nCoV-19 vaccine. The volunteers, who will be drawn from the local Oxford region, will be followed for a total of four months.
This is surely a very worthwhile study.
Not to be sniffed at!
Comment by Stephen Spark | March 27, 2021 |